Podcast Episodes
Back to Search
Relief and Volatility Ahead for U.S. Stocks
Episode 1513
Our CIO and Chief U.S. Equity Strategist Mike Wilson unpacks why stocks are likely to stay resilient despite uncertainties related to Fed rates, gov…
9 months, 4 weeks ago
Fed’s Path Uncertain as Key Data Lags
Episode 1512
Our Chief U.S. Economist Michael Gapen and Global Head of Macro Strategy Matthew Hornbach discuss potential next steps for the FOMC and the risks to …
10 months ago
Supreme Court Tests Trump Tariffs
Episode 1511
Earlier this week, the U.S. Supreme Court heard a case challenging the current administration’s tariff policy. Our Head of Fixed Income Research and …
10 months ago
Future of Work: AI’s Paradigm Shift for Labor
Episode 1510
Concluding a two-part roundtable discussion, our global heads of Research, Thematic Research and Firmwide AI focus on the human impacts of AI adoptio…
10 months ago
Future of Work: AI’s Impact on Industries
Episode 1509
In the first of a two-part roundtable discussion, our Global Head of Research joins our Global Head of Thematic Research and Head of Firmwide AI to d…
10 months ago
More Confidence in a Bull Market
Episode 1508
Our CIO and Chief U.S. Equity Strategist Mike Wilson looks at buying opportunities approaching year-end, as U.S. trade policy and the Fed find middle…
10 months ago
How Japan’s Stablecoin Could Reshape Global Finance
Episode 1507
Our Japan Financials Analyst Mia Nagasaka discusses how the country’s new stablecoin regulations and digital payments are set to transform the flow o…
10 months, 1 week ago
Why Shutdown Standoff Raises Stakes for Healthcare
Episode 1506
Our analysts Ariana Salvatore and Erin Wright explain the pivotal role of healthcare in negotiations to end the government shutdown.
Read more insight…
10 months, 1 week ago
M&A Poised to Gain Momentum
Episode 1505
Our Head of Corporate Credit Research Andrew Sheets explains why the recent revival of M&A activity has room to accelerate.
Read more insights from Mo…
10 months, 1 week ago
A Turnaround in Sight for Healthcare?
Episode 1504
Our U.S. Biotech and Biopharma analysts Sean Laaman and Terence Flynn discuss the latest developments that could be positioning the healthcare sector…
10 months, 1 week ago